April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Visual Field Progression In Glaucoma: The Specificity of the Guided Progression Analysis Varies Considerably Between Individual Patients
Author Affiliations & Notes
  • Paul H. Artes
    Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada
  • Glen P. Sharpe
    Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada
  • Neil O'Leary
    Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada
  • David P. Crabb
    Optometry and Visual Science, City University, London, United Kingdom
  • Footnotes
    Commercial Relationships  Paul H. Artes, None; Glen P. Sharpe, None; Neil O'Leary, None; David P. Crabb, None
  • Footnotes
    Support  Glaucoma Research Foundation (PHA, DPC)
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4148. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Paul H. Artes, Glen P. Sharpe, Neil O'Leary, David P. Crabb; Visual Field Progression In Glaucoma: The Specificity of the Guided Progression Analysis Varies Considerably Between Individual Patients. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4148.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To estimate the specificity of the Guided Progression Analysis (GPA, Carl Zeiss Meditec, CA), in individual patients.

Methods: : One eye of 30 glaucoma patients (Mean Deviation [MD], mean -3.3 dB, range -10.7 to +1.2 dB) was tested 12 times in 3 months (SITA-Standard 24-2 test). "Likely progression" or "possible progression" was determined with an analysis similar to the GPA where black triangles identify locations with significant change from baseline (mean of tests 1 and 2) in 3 or 2 consecutive follow-up tests, respectively. These analyses were repeated after the tests were randomly rearranged in time (100 permutations per series).

Results: : The average specificity of the GPA was high - for the entire sample, the false positive (FP) rates for "likely progression" and "possible progression" after 10 follow-up tests were 1.3% and 10%. However, FP rates varied substantially between patients, from less than 1% to approximately 8% with "likely progression" and from less than 1% to approximately 40% with "possible progression". Factors associated with FP events were visual field variability (SD of MD, Spearman rank correlation coefficient r=0.23, p=0.03) but not overall severity of damage (average MD, Pattern Standard Deviation, p>0.1) or any of the reliability indices (average rates of false-positive and false negative responses, fixation losses, p>0.3).

Conclusions: : On average, progression criteria currently employed in the GPA have high specificity, but some patients are up to 40 times more likely to show a false-positive event than others. These finding are important when the GPA is used in the clinical management of patients and in clinical trials. Because the consistency of visual field results varies greatly between patients, criteria for point-by-point change should be adapted to individual patients.

Keywords: visual fields • perimetry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×